The GR group compared to the BR group had significant enrichment in CD3+ (stroma—p < 0.001, tumor—p < 0.001), CD8+ (stroma—p = 0.001, tumor—p < 0.001), CD4+ (stroma—p = 0.009, tumor—p = 0.004), and CD45R0+ (tumor—p = 0.014) cells. Here, CD8A is linked to neoplasm.